Tinea Capitis Clinical Presentation
- Author: Grace F Kao, MD; Chief Editor: Dirk M Elston, MD more...
History
- Tinea capitis begins as a small erythematous papule around a hair shaft on the scalp, eyebrows, or eyelashes.
- Within a few days, the red papule becomes paler and scaly, and the hairs appear discolored, lusterless, and brittle. They break off a few millimeters above the scalp skin surface.
- The lesion spreads, forming numerous papules in a typical ring form. Ring-shaped lesions may coalesce with other infected areas.
- Pruritus usually is minimal but may be intense at times.
- Alopecia is common in infected areas.
- Inflammation may be mild or severe. Deep boggy red areas characterized by a severe acute inflammatory infiltrate with pustule formation are termed kerions or kerion celsi (see the image below).
Typical lesions of kerion celsi on the vertex scalp of a young Chinese boy. Note numerous bright yellow purulent areas on skin surface, surrounded by adjacent edematous, erythematous, alopecic areas. Culture from the lesion grew Trichophyton mentagrophytes. Courtesy of Skin Diseases in Chinese by Yau-Chin Lu, MD. Permission granted by Medicine Today Publishing Co, Taipei, Taiwan, 1981. - Favus (also termed tinea favosa) is a severe form of tinea capitis.
- Favus is a chronic infection caused most commonly by T schoenleinii and, occasionally, by T violaceum or Microsporum gypsum.
- Scalp lesions are characterized by the presence of yellow cup-shaped crusts termed scutula, which surround the infected hair follicles.
- Favus is seen predominantly in Africa, the Mediterranean, and the Middle East and, rarely, in North America and South America, usually in descendants of immigrants from endemic areas.
- Favus usually is acquired early in life and has a tendency to cluster in families.
- In favus, infected hairs appear yellow.
Physical
A variety of clinical presentations of tinea capitis are recognized as being inflammatory or noninflammatory and are usually associated with patchy alopecia. However, the infection may be widespread, and the clinical appearances can be subtle. In urban areas, tinea capitis should be considered in the differential diagnosis of children older than 3 months with a scaly scalp until proven negative by mycological examination. Infection may also be associated with painful regional lymphadenopathy, especially in the inflammatory variants.
Pertinent physical findings are limited to the skin of scalp, eyebrows, and eyelashes.
- Primary skin lesions of tinea capitis
- Lesions begin as red papules with progression to grayish ring-formed patches containing perifollicular papules.
- Pustules with inflamed crusts, exudate, matted infected hairs, and debris may be seen.
- Black dot tinea capitis refers to an infection with fracture of the hair, leaving the infected dark stubs visible in the follicular orifices.
- Kerion celsi may progress to a patchy or diffuse distribution and to severe hair loss with scarring alopecia (see the image below).
Discrete patches of hair loss or alopecia caused by Trichophyton violaceum infection of the vertex scalp of a young Taiwanese boy. Courtesy of Skin Diseases in Chinese by Yau-Chin Lu, MD. Permission granted by Medicine Today Publishing Co, Taipei, Taiwan, 1981.
- Id reaction: Dermatophyte idiosyncratic or id reactions are manifestations of the immune response to dermatophytosis.
- Id reactions occur at a distant site, and the lesions are devoid of organisms.
- Id reactions may be triggered by antifungal treatment.
- The most common type of id reaction is an acute vesicular dermatitis of the hands and feet. The grouped vesicles are tense, pruritic, and sometimes painful. Id reactions are noted in patients with inflammatory ringworm of the feet, primarily resulting from infection by Trichophyton mentagrophytes. Similar lesions may occur on the trunk in tinea capitis.
- Vesicular lesions may evolve into a scaly eczematoid reaction or a follicular papulovesicular eruption.
- Other less common types of id reactions include annular erythema and erythema nodosum. These patients have a strong delayed-type hypersensitivity reaction to intradermal trichophytin.
- Distribution of tinea capitis lesions: Skin lesions appear on the scalp with extension to the eyebrows and/or eyelashes.
- Regional lymph nodes: Cervical lymphadenopathy may develop in patients with severe inflammation associated with kerion formation.
Causes
- Infection of the scalp by dermatophytes usually is the result of person-to-person transmission. The organism remains viable on combs, brushes, couches, and sheets for long periods. Certain species of dermatophytes are endemic only in particular parts of the world. Zoophilic fungal infections of the scalp are rare.
- In the United States, T tonsurans has replaced M audouinii and M canis as the most common cause of tinea capitis. T tonsurans also is the most common cause of the disease in Canada, Mexico, and Central America.
- Historically, M audouinii was the classic causative agent in Europe and America and M ferrugineum was most common in Asia. Currently, M audouinii and M canis remain prevalent in most parts of Europe, although T violaceum also is common in Romania, Italy, Portugal, Spain, and the former USSR, as well as in Yugoslavia. In Africa, T violaceum, T schoenleinii, and M canis commonly are isolated.[1]T violaceum and M canis are prevalent agents in Asia.[2]T schoenleinii is common in Iran and Turkey, while M canis is common in Israel. Epidermophyton floccosum and T concentricum do not invade scalp hair. Trichophyton rubrum, which is the most common dermatophyte isolated worldwide, is not a common cause of tinea capitis.
- Dermatophytic fungi causing tinea capitis can be divided into anthropophilic and zoophilic organisms. Anthropophilic fungi grow preferentially on humans, and the most common type forms large conidia of approximately 3-4 µm in diameter within the hair shaft. Zoophilic fungi are acquired through direct contact with infected animals. Smaller conidia of approximately 1-3 µm in diameter typically are present, extending around the exterior of the hair shaft.
- Dermatophytosis customarily is divided into endothrix (inside the hair shaft) and ectothrix (extending outside the hair shaft) infection based on the location of proliferation of pathogenic fungi and destruction of the hair structure.
- Common causes of endothrix infection include T tonsurans, characterized by chains of large spores and T schoenleinii, characterized by hyphae with air spaces. Infected hairs break off sharply at the follicular orifice, leaving a conidia-filled stub or black dot. Suppuration and kerion formation (see the image below) commonly are associated with T tonsurans infection.
Typical lesions of kerion celsi on the vertex scalp of a young Chinese boy. Note numerous bright yellow purulent areas on skin surface, surrounded by adjacent edematous, erythematous, alopecic areas. Culture from the lesion grew Trichophyton mentagrophytes. Courtesy of Skin Diseases in Chinese by Yau-Chin Lu, MD. Permission granted by Medicine Today Publishing Co, Taipei, Taiwan, 1981. - In ectothrix infection, fragmentation of the mycelium into spores occurs just beneath the cuticle. In contrast to endothrix infection, destruction of the cuticle occurs. This type of infection is caused by T verrucosum, T mentagrophytes, and all Microsporum species.
Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. Nov-Dec 2008;166(5-6):335-52. [Medline].
Kondo M, Nakano N, Shiraki Y, Hiruma M, Ikeda S, Sugita T. A Chinese-Japanese boy with black dot ringworm due to Trichophyton violaceum. J Dermatol. Mar 2006;33(3):165-8. [Medline].
Akbaba M, Ilkit M, Sutoluk Z, Ates A, Zorba H. Comparison of hairbrush, toothbrush and cotton swab methods for diagnosing asymptomatic dermatophyte scalp carriage. J Eur Acad Dermatol Venereol. Mar 2008;22(3):356-62. [Medline].
Friedlander SF, Pickering B, Cunningham BB, Gibbs NF, Eichenfield LF. Use of the cotton swab method in diagnosing Tinea capitis. Pediatrics. Aug 1999;104(2 Pt 1):276-9. [Medline].
Bonifaz A, Isa-Isa R, Araiza J, Cruz C, Hernández MA, Ponce RM. Cytobrush-culture method to diagnose tinea capitis. Mycopathologia. Jun 2007;163(6):309-13. [Medline].
Trovato MJ, Schwartz RA, Janniger CK. Tinea capitis: current concepts in clinical practice. Cutis. Feb 2006;77(2):93-9. [Medline].
Slowinska M, Rudnicka L, Schwartz RA, et al. Comma hairs: a dermatoscopic marker for tinea capitis: a rapid diagnostic method. J Am Acad Dermatol. Nov 2008;59(5 Suppl):S77-9. [Medline].
Gupta AK, Cooper EA, Bowen JE. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis. J Drugs Dermatol. Apr 2008;7(4):369-72. [Medline].
Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. Nov 2004;114(5):1312-5. [Medline].
[Best Evidence] Gonzalez U, Seaton T, Bergus G, Jacobson J, Martinez-Monzon C. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. Oct 17 2007;CD004685. [Medline].
Gupta AK, Hofstader SL, Adam P, Summerbell RC. Tinea capitis: an overview with emphasis on management. Pediatr Dermatol. May-Jun 1999;16(3):171-89. [Medline].
Koumantaki-Mathioudaki E, Devliotou-Panagiotidou D, Rallis E, et al. Is itraconazole the treatment of choice in Microsporum canis tinea capitis?. Drugs Exp Clin Res. 2005;31 Suppl:11-5. [Medline].
Friedlander SF, Aly R, Krafchik B, et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics. Apr 2002;109(4):602-7. [Medline].
Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol. Jul 1999;41(1):60-3. [Medline].
Ghannoum MA, Wraith LA, Cai B, Nyirady J, Isham N. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial. Br J Dermatol. Sep 2008;159(3):711-3. [Medline].
[Best Evidence] Elewski BE, Caceres HW, DeLeon L, et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol. Jul 2008;59(1):41-54. [Medline].
Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. Apr 2011;64(4):663-70. [Medline].
Friedlander SF, Aly R, Krafchik B, et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics. Apr 2002;109(4):602-7. [Medline].
White JM, Higgins EM, Fuller LC. Screening for asymptomatic carriage of Trichophyton tonsurans in household contacts of patients with tinea capitis: results of 209 patients from South London. J Eur Acad Dermatol Venereol. Sep 2007;21(8):1061-4. [Medline].
Pomeranz AJ, Sabnis SS, McGrath GJ, Esterly NB. Asymptomatic dermatophyte carriers in the households of children with tinea capitis. Arch Pediatr Adolesc Med. May 1999;153(5):483-6. [Medline].
Williams JV, Honig PJ, McGinley KJ, Leyden JJ. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children. Pediatrics. Aug 1995;96(2 Pt 1):265-7. [Medline].
Arenas R, Toussaint S, Isa-Isa R. Kerion and dermatophytic granuloma. Mycological and histopathological findings in 19 children with inflammatory tinea capitis of the scalp. Int J Dermatol. Mar 2006;45(3):215-9. [Medline].
Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. Jan 2000;42(1 Pt 1):1-20; quiz 21-4. [Medline].
Elewski BE. Cutaneous fungal infections. In: Topics in Dermatology. Tokyo, Japan: Igaku-Shoin; 1992.
Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol. Jun 1999;40(6 Pt 2):S27-30. [Medline].
Ergin S, Ergin C, Erdogan BS, Kaleli I, Evliyaoglu D. An experience from an outbreak of tinea capitis gladiatorum due to Trichophyton tonsurans. Clin Exp Dermatol. Mar 2006;31(2):212-4. [Medline].
Gorbach SL, Bartlett JG, Zorab R, Blacklow NR , eds. Dermatophyte infections of the hair, tinea capitis in fungal infections of the skin. In: Infectious Diseases. 2nd ed. Philadelphia, Pa: WB Saunders; 1997:1276-95.
Hay RJ. Clinical manifestations and management of superficial fungal infection in the compromised patient. In: Warnock DW, Richardson MD, eds. Fungal Infection in the Compromised Patient. New York, NY: John Wiley & Sons; 1992.
Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, Pa: Lea & Febiger; 1992.
[Guideline] MacKenzie DWR, Loeffler W, Mantovani A, Fujikura T. Guidelines for the diagnosis, prevention and control of dermatophytosis in man and animals. World Health Organization WHO/CDS/VPH/86.67. 1986.
Mandell GL, Bennett JE, Dolin R, eds. Tinea capitis in dermatophytosis and other superficial mycosis. In: Principles and Practice of Infectious Disease. 1995. New York, NY: Churchill Livingstone; 2379-82.
Richardson MD, Warnock DW. Fungal Infection: Diagnosis and Management. London, England: Blackwell Scientific; 1993.
Rippon JW. Medical Mycology. 3rd ed. Philadelphia, Pa: WB Saunders; 1988.
Rippon JW. Tinea capitis in dermatophytosis and dermatomycosis. In: Medical Mycology, the Pathogenic Fungi and the Pathogenic Actinomycetes. Philadelphia, Pa: WB Saunders; 1988:186-96.
Rook A, Dawber R. Ringworm of the scalp. In: Infections and Infestations: Diseases of the Hair and Scalp. London, England: Blackwell Science; 1982:367-85.
Smith ML. Tinea capitis. Pediatr Ann. Feb 1996;25(2):101-5. [Medline].
Stein DH. Tineas--superficial dermatophyte infections. Pediatr Rev. Nov 1998;19(11):368-72. [Medline].
Yau-Chin Lu. Tinea capitis. In: Skin Diseases in Chinese. Taipei, Taiwan: Medicine Today; 1981:203-6.

